North America MRI Systems Market Outlook to 2033: 3T MRI Systems, 1.5T MRI Systems and 0.2T-1.2T MRI Systems

All the vital news, analysis, and commentary curated by our industry experts.

$5995

Buy Report

Published: September 04, 2025 Report Code: GDME20451CRDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “North America MRI Systems Market Outlook to 2033” is a comprehensive databook report, covering key market data on the North America MRI Systems market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – 3T MRI Systems, 1.5T MRI Systems and 0.2T-1.2T MRI Systems

The North America MRI Systems Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2023 company share data for MRI Systems Market.
• Global corporate-level profiles of key companies operating within the North America MRI Systems Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America MRI Systems is segmented as follows – _x000D_

• 3T MRI Systems_x000D_

• 1.5T MRI Systems_x000D_

• 0.2T-1.2T MRI Systems

Reasons to Buy

The North America MRI Systems Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Siemens Healthineers AG_x000D_
GE HealthCare Technologies Inc_x000D_
Philips Healthcare Informatics Inc_x000D_
Canon Medical Systems Corp

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 7

2 Introduction 8

2.1 What Is This Report About? 8

2.2 MRI Systems Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 8

3 MRI Systems Market, North America 9

3.1 MRI Systems Market, North America, Revenue ($m), 2018-2033 9

3.2 MRI Systems Market, North America, Revenue ($m), 2018-2033 10

3.3 MRI Systems Market, North America, Volume (Units), 2018-2033 12

3.4 MRI Systems Market, North America, Volume (Units), 2018-2033 13

3.5 MRI Systems Market, North America, Company Share by Revenue ($m), 2024 15

4 MRI Systems Market, Mexico 16

4.1 MRI Systems Market, Mexico, Revenue ($m), 2018-2033 16

4.2 MRI Systems Market, Mexico, Volume (Units), 2018-2033 18

4.3 MRI Systems Market, Mexico, Average Price ($), 2018-2033 20

4.4 MRI Systems Market, Mexico, Company Share by Revenue ($m), 2024 21

5 MRI Systems Market, Canada 22

5.1 MRI Systems Market, Canada, Revenue ($m), 2018-2033 22

5.2 MRI Systems Market, Canada, Volume (Units), 2018-2033 24

5.3 MRI Systems Market, Canada, Average Price ($), 2018-2033 25

5.4 MRI Systems Market, Canada, Company Share by Revenue ($m), 2024 26

6 MRI Systems Market, United States 27

6.1 MRI Systems Market, United States, Revenue ($m), 2018-2033 27

6.2 MRI Systems Market, United States, Volume (Units), 2018-2033 29

6.3 MRI Systems Market, United States, Average Price ($), 2018-2033 31

6.4 MRI Systems Market, United States, Company Share by Revenue ($m), 2024 32

7 Overview of Key Companies in North America MRI Systems Market 33

7.1 Siemens Healthineers AG 33

7.1.1 Company Overview 33

7.2 GE HealthCare Technologies Inc 33

7.2.1 Company Overview 33

7.3 Philips Healthcare Informatics Inc 33

7.3.1 Company Overview 33

7.4 Canon Medical Systems Corp 33

7.4.1 Company Overview 33

8 MRI Systems Market Pipeline Products 34

9 Recent Developments 39

9.1 Corporate Communications 39

9.1.1 Feb 21, 2025: Noris Medical Receives FDA 510(k) Clearance for LONGY-N Implant 39

9.1.2 Feb 21, 2025: Bruker Adds Laura Francis to Board of Directors 39

9.1.3 Dec 09, 2024: Hologic Appoints Dr. Martin Madaus to Its Board 39

9.1.4 Sep 03, 2024: Butterfly Network Appoints Steve Cashman as Chief Business Officer 40

9.1.5 Sep 03, 2024: Polarean Imaging Appoints Alan Huang as Vice President of Sales 40

9.1.6 Sep 03, 2024: Polarean Imaging Announces Appointment of Vice President of Sales 41

9.2 Financial Announcements 41

9.2.1 Jul 02, 2025: Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025 41

9.2.2 Apr 17, 2025: GE HealthCare to Announce First Quarter 2025 Results on April 30, 2025 42

9.2.3 Mar 19, 2025: iCAD Posts Results for Q4 and Fiscal Year Ended December 31, 2024 42

9.2.4 Mar 12, 2025: Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business 43

9.2.5 Feb 27, 2025: Polarean Imaging Announces FY24 Trading Update 44

9.2.6 Feb 05, 2025: Hologic Reports Results for Q1 of Fiscal 2025 45

9.2.7 Jan 27, 2025: Progentec Diagnostics' Proprietary aiSLE DX FRI and DAI Lupus Biomarker Tests Receive PLA Codes and Final Payment Determination from the Centers of Medicare and Medicaid Services 46

9.2.8 Jan 08, 2025: Butterfly Network Reports Preliminary, Unaudited Fourth Quarter 2024 Revenue Growth of Approximately 35% Year over Year 47

9.2.9 Jan 06, 2025: Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025 47

9.2.10 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025 48

9.2.11 Nov 12, 2024: Oxford Instruments Announces Half-Year Results 48

9.2.12 Nov 12, 2024: Fonar Announces Financial Results for the 1st Quarter of Fiscal 2025 49

9.2.13 Oct 17, 2024: ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024 50

9.2.14 Oct 04, 2024: Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024 50

9.2.15 Aug 01, 2024: Butterfly Network Releases Q2 2024 Results 50

9.2.16 Jul 17, 2024: ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024 52

9.3 Government and Public Interest 52

9.3.1 Jun 02, 2025: Yuhan Collects $15 Mil. As J&J Lung Cancer Combo Hits Japan 52

9.3.2 Mar 17, 2025: Enveric Biosciences Participating in BIO-Europe Spring 53

9.3.3 Feb 13, 2025: Unimom Receives Additional 510(K) Clearance For VIVACE Powered Breast Pump 53

9.3.4 Feb 10, 2025: GE Healthcare Management to Present at Upcoming Investor Conference 54

9.3.5 Jan 29, 2025: Update on the Episurf MTP Implant – Response to FDA Submitted 54

9.3.6 Dec 20, 2024: FDA Approves First Acellular Tissue Engineered Vessel to Treat Vascular Trauma in Extremities 54

9.3.7 Dec 03, 2024: Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed 55

9.3.8 Nov 20, 2024: IAC Releases Updates to IAC Standards & Guidelines for MRI Accreditation 56

9.3.9 Oct 29, 2024: Celltrion Presents Post Hoc Analysis of Liberty Studies of Zymfentra at the ACG 2024 Annual Scientific Meeting 57

9.3.10 Oct 15, 2024: Electronic Medical Devices, X-ray Imaging and Radiation Therapy: What to Know and How to Prevent Damage 58

9.3.11 Sep 25, 2024: Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study 59

9.3.12 Aug 23, 2024: Nurexone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Conferences 60

9.3.13 Jul 29, 2024: Zimmer MedizinSysteme Receives FDA 510(k) Clearance for RFG-01 61

9.4 Legal And Regulatory 61

9.4.1 Jul 01, 2025: Shenzhen Wikkon Precision Instruments Receives 510(K) Clearance For U200 Extracorporeal Shock Wave Lithotripter 61

9.4.2 Sep 13, 2024: Hansoh Pharma Released the Phase II Clinical Study Data of the Novel Dual GIP and GLP-1 Receptor Agonist 61

9.5 Other Significant Developments 63

9.5.1 Jun 16, 2025: Debiopharm’s ADC Research Gains Momentum With Launch of First-in-human Trial Assessing Debio 1562M in Acute Myeloid Leukemia Patients 63

9.5.2 May 09, 2025: Mediso Completes First Phase of Strategic Technology Transfer Agreement With Superconducting Systems 64

9.5.3 Apr 28, 2025: SLUHN Invests in AI-Enabled MRI Technology from GE HealthCare 65

9.5.4 Apr 23, 2025: Eugia Pharma Receives USFDA Approval for Dasatinib Tablets 65

9.5.5 Apr 08, 2025: 3D Printing and Visualization: A New Dimension of CT and MRI 66

9.5.6 Apr 07, 2025: Reducing Scan Times for MRIs With Quantum Technologies 66

9.5.7 Mar 18, 2025: Subtle Medical Advances GenAI Innovation in Radiology with NVIDIA 67

9.5.8 Mar 12, 2025: Forest City Diagnostic Imaging Expands Operations, Touts Its MRI AI-powered Technology, and Unveils Its Latest 2024 Siemens CT Scanner 68

9.5.9 Jan 07, 2025: InkSpace Imaging Receives Additional 510(K) Clearance For Imaging Body Array 68

9.5.10 Dec 30, 2024: Imricor Continues Global Expansion with First Sale in the Middle East 69

9.5.11 Dec 19, 2024: VSee Health Receives Teleradiology Contract With Post-Acute Care Hospital System 69

9.5.12 Dec 02, 2024: Nurix Therapeutics Announces Webcast To Review Data from Phase 1 Clinical Trial of BTK Degrader NX-5948 Presented at the 66th ASH Annual Meeting 70

9.5.13 Nov 12, 2024: Rocket to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the AHA 2024 Late-Breaking Science Sessions 70

9.5.14 Oct 14, 2024: Norton Healthcare Acquires Groundbreaking Focused Ultrasound Technology 71

9.5.15 Sep 08, 2024: Avalyn Presents Multiple Posters on AP01 for PPF, Including MIST Phase 2B Trial Design and ATLAS Phase 1B Study Post-hoc Analyses, at ERS 2024 72

9.5.16 Jul 19, 2024: Xenon MRI System Trade-in Agreement Entered with the University of Virginia Health Hospital 73

9.6 Product News 74

9.6.1 Jun 02, 2025: New Headache Medicine Research Impacting Treatment, Prevention and Quality of Life to be Presented at the American Headache Society 67th Annual Scientific Meeting in Minneapolis, MN 74

9.6.2 May 08, 2025: Cutting-edge MRI Could Revolutionise Diagnosis of Common Heart Problem Aortic Stenosis 74

9.6.3 Mar 03, 2025: UTSW Researchers Use Focused Ultrasound to Identify Stroke Biomarkers 75

9.6.4 Feb 27, 2025: New 4D Brain Map Reveals Potential Early Warning Signs of Multiple Sclerosis 76

9.6.5 Feb 25, 2025: UH Researchers Paving the Way for New Era in Medical Imaging 77

9.6.6 Feb 18, 2025: Voyageur Advances MRI Drug Development Using Next Generation Endohedral Fullerenes 77

9.6.7 Dec 10, 2024: Portable MRI Shows Promise for Expanding Brain Imaging for Alzheimer’s Disease 78

9.6.8 Nov 29, 2024: Interim Diagnostic Imaging and Modular Devices Unveil New Innovation in Mobile Medical Imaging 79

9.6.9 Oct 17, 2024: INFINITT North America Revolutionizes Breast MRI Tracking with Groundbreaking New Solution 79

9.6.10 Oct 01, 2024: Plus Therapeutics Reports ReSPECT-GBM Clinical Trial Update at the 2024 Congress of Neurological Surgeons Annual Meeting 80

9.6.11 Sep 17, 2024: New Method Created for Improving the Resolution of Routine Medical Images 81

9.6.12 Sep 13, 2024: Endo Presents Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 81

9.6.13 Sep 06, 2024: Targeted Therapy For Parkinson's Disease: Breakthrough in Real-Time MRI-Guided Stem Cell Transplantation 82

9.6.14 Sep 05, 2024: Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution

0.75% for Presbyopia 83

9.6.15 Aug 21, 2024: The STAR Consortium Announces a Major Milestone in Crohn's Disease Intestinal Strictures Imaging 86

9.6.16 Jul 09, 2024: Intensity Therapeutics Announces First Patient Dosed in Its Global Randomized, Phase 3 Study (Invincible-3) in Metastatic Soft Tissue Sarcoma 87

9.6.17 Jul 08, 2024: Capital Health Partnering with TVAX Biomedical to Offer Brain Cancer Immunotherapy Trial 88

9.7 Strategy And Business Planning 88

9.7.1 Jun 03, 2025: Matter Neuroscience Launches Collaboration With Stanford Medicine 88

9.7.2 May 13, 2025: Philips and NVIDIA partner to leverage AI for MR imaging 89

9.7.3 Mar 12, 2025: Forest City Diagnostic Imaging Expands Operations, Touts Its MRI AI-powered Technology, and Unveils Its Latest 2024 Siemens CT Scanner 89

9.7.4 Feb 18, 2025: Voyageur Advances MRI Drug Development Using Next Generation Endohedral Fullerenes 90

9.7.5 Jan 10, 2025: Imaging Biometrics and Prism Clinical Imaging Secure First Installation 91

9.7.6 Dec 04, 2024: Lisata and Kuva Labs partner for MR imaging agents to detect cancer 91

9.7.7 Oct 16, 2024: Ezra, Full-Body MRI Leader, Launches AI-Powered Scans to Philadelphia in Partnership with Princeton Radiology 91

9.7.8 Aug 20, 2024: Prism Clinical Imaging and Sora Neuroscience Sign Cooperation Agreement 92

9.7.9 Aug 08, 2024: Youngstown Orthopaedic Associates and The Orthopaedic Surgery Center in Youngstown Name Medline as Prime Vendor 92

10 Appendix 94

10.1 Research Methodology 95

10.1.1 Coverage 95

10.1.2 Secondary Research 95

10.1.3 Primary Research 95

10.1.4 Market Modeling and Forecasting 96

10.1.5 Company Share Analysis 97

10.1.6 Benchmarking 98

10.2 GlobalData Consulting 98

10.3 Contact Us 98

10.4 Disclaimer 99

Table

Table 1: MRI Systems Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 9

Table 2: MRI Systems Market, North America, Revenue ($m), USD Constant, 2018-2033 11

Table 3: MRI Systems Market, North America, Volume (Units), 2018-2033 12

Table 4: MRI Systems Market, North America, Volume (Units), 2018-2033 14

Table 5: MRI Systems Market, North America, Company Share by Revenue ($m), 2024 15

Table 6: MRI Systems Market, Mexico, Revenue ($m), USD Constant, 2018-2033 17

Table 7: MRI Systems Market, Mexico, Volume (Units), 2018-2033 19

Table 8: MRI Systems Market, Mexico, Average Price ($), 2018-2033 20

Table 9: MRI Systems Market, Mexico, Company Share by Revenue ($m), 2024 21

Table 10: MRI Systems Market, Canada, Revenue ($m), USD Constant, 2018-2033 23

Table 11: MRI Systems Market, Canada, Volume (Units), 2018-2033 24

Table 12: MRI Systems Market, Canada, Average Price ($), 2018-2033 25

Table 13: MRI Systems Market, Canada, Company Share by Revenue ($m), 2024 26

Table 14: MRI Systems Market, United States, Revenue ($m), USD Constant, 2018-2033 28

Table 15: MRI Systems Market, United States, Volume (Units), 2018-2033 30

Table 16: MRI Systems Market, United States, Average Price ($), 2018-2033 31

Table 17: MRI Systems Market, United States, Company Share by Revenue ($m), 2024 32

Table 18: MRI Systems Market Pipeline Products 34

Table 19: Total Number of Primary Research Participants, Diagnostic Imaging Market, by Country 96

Figures

Figure 1: MRI Systems Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 9

Figure 2: MRI Systems Market, North America, Revenue ($m), USD Constant, 2018-2033 10

Figure 3: MRI Systems Market, North America, Volume (Units), 2018-2033 12

Figure 4: MRI Systems Market, North America, Volume (Units), 2018-2033 13

Figure 5: MRI Systems Market, North America, Company Share (%), 2024 15

Figure 6: MRI Systems Market, Mexico, Revenue ($m), USD Constant, 2018-2033 16

Figure 7: MRI Systems Market, Mexico, Volume (Units), 2018-2033 18

Figure 8: MRI Systems Market, Mexico, Company Share (%), 2024 21

Figure 9: MRI Systems Market, Canada, Revenue ($m), USD Constant, 2018-2033 22

Figure 10: MRI Systems Market, Canada, Volume (Units), 2018-2033 24

Figure 11: MRI Systems Market, Canada, Company Share (%), 2024 26

Figure 12: MRI Systems Market, United States, Revenue ($m), USD Constant, 2018-2033 27

Figure 13: MRI Systems Market, United States, Volume (Units), 2018-2033 29

Figure 14: MRI Systems Market, United States, Company Share (%), 2024 32

North America MRI Systems Market Outlook to 2033: 3T MRI Systems, 1.5T MRI Systems and 0.2T-1.2T MRI Systems standard reports

Currency USD

Single User

$5,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Diagnostic Imaging reports

Medical Devices

New

Global M&A Deals in H1 2026 - Top Themes by…

Medical Devices

New

Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…

Medical Devices

New

AI-designed Materials: Market Trends and Innovations

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America MRI Systems Market Outlook to 2033: 3T MRI Systems, 1.5T MRI Systems and 0.2T-1.2T MRI Systems in real time.

Access a live North America MRI Systems Market Outlook to 2033: 3T MRI Systems, 1.5T MRI Systems and 0.2T-1.2T MRI Systems dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

North America MRI Systems Market Outlook to 2033: 3T MRI Systems, 1.5T MRI Systems and 0.2T-1.2T MRI Systems

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports